Pablo Garcia-Polo1,
2, Daniel Garcia-Frank3, Alicia Quiros4, Zhongmin
Lin5, Litao Yan5, Gopal Avinash5, Roberto
Garcia-Alvarez6, Juan lvarez-Linera7, Juan Antonio
Hernandez-Tamames1, 2
1DTE,
Universidad Rey Juan Carlos, Mstoles, Madrid, Spain; 2CIBERNED,
Alzheimer's Project Queen Sofia Foundation, Madrid, Spain; 3IDIPAZ,
FIBHULP, Madrid, Spain; 4Universidad Rey Juan Carlos, Fuenlabrada,
Madrid, Spain; 5GE Healthcare, Waukesha, WI, United States; 6GE
Healthcare, Madrid, Spain; 7Hospital Ruber Internacional, Madrid,
Spain
This piece of work compares structural, metabolic and physiological biomarkers in order to characterize the Alzheimers disease, which is the most common cause of dementia, with neuroimaging methods.